DKSH Holding AG (DKSH) AI Stock Analysis

• Market Cap: CHF3.86B
• Dividend Yield: 4.14%
• Average Volume (3M): 92.63K
• Price to Earnings (P/E): 18.4
• Beta (1Y): 0.90
• Revenue Growth: 2.66%
• EPS Growth: 2.91%
• Country: CH
• Employees: 26,167
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 1.71
• Shares Outstanding: 65,042,960
• 10 Day Avg. Volume: 85,614
• 30 Day Avg. Volume: 92,626
• PEG Ratio: -3.37
• Price to Book (P/B): 2.13
• Price to Sales (P/S): 0.34
• P/FCF Ratio: 13.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF73.50
• Price Target Upside: 23.74% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 3.67
• Revenue Forecast (FY): CHF11.27B

• Rating: 67 Neutral
• Price Target: CHF69.00 ▲(16.16% Upside)
• Action: Downgraded Date: 02/23/26
• Date: Action: Downgraded 02/23/26

The score is driven primarily by stable but mid-range financial performance (thin margins and some 2025 volatility), supported by strong technical momentum and a generally constructive earnings call highlighting improving core EBIT and strong cash conversion. Valuation is acceptable rather than cheap, with the dividend yield providing partial support.

Positive Factors

Very strong cash generation

Sustained high cash conversion (95.2%) and positive free cash flow provide durable internal funding for M&A, dividends and deleveraging. This supports capital allocation discipline, reduces reliance on external financing and underpins shareholder returns over the medium term.

Leading Asia/Healthcare presence

A dominant Healthcare business and strong Asia exposure position DKSH in faster-growing end markets and higher-value commercial outsourcing. This structural mix drives more resilient revenue and margin uplift potential relative to more cyclical, commodity-focused peers.

Asset-light model & operational efficiency

Low capex and multi-year logistics savings strengthen an asset-light model that enhances return on capital. Durable cost efficiencies and optimized working capital support margin expansion and scalable growth without heavy incremental investment needs.

Negative Factors

Structurally thin margins

Consistently low operating and net margins limit the company's buffer against cost inflation or adverse cycles. Thin profitability means smaller absolute EBIT improvements are required to offset shocks, constraining long-term earnings resilience versus higher-margin competitors.

Upward drift in leverage

A modest rise in leverage reduces balance-sheet flexibility and could constrain funding optionality for larger, transformational deals or defensive capital needs. In tighter macro conditions higher leverage amplifies refinancing and covenant risks over the medium term.

Business volatility in parts of portfolio

Cyclical and regulatory sensitivities in Performance Materials and delayed Technology investments create uneven earnings contribution. These structural volatilities can impair predictable margin progression and make near-to-medium-term performance more lumpy despite overall diversification.

DKSH Holding AG Business Overview & Revenue Model

Company Description

DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, marketing, sales, distribution, and after-sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for ethical pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and fashion and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.

How the Company Makes Money

DKSH generates revenue through a diversified model primarily based on providing market expansion services to its clients. Key revenue streams include service fees for marketing and sales support, logistics and distribution services, and commissions from product sales. The company partners with a wide range of suppliers and brands, which allows it to leverage existing product lines and introduce new products to the market. Significant partnerships with major global brands in the consumer goods and healthcare sectors contribute to its earnings, as these collaborations enhance DKSH's portfolio and market presence. Additionally, the company benefits from economies of scale and operational efficiencies, which help improve profit margins across its various services.

DKSH Holding AG Financial Statement Overview

Summary

Mid-range fundamentals: revenue and earnings have been broadly stable over multiple years with consistently positive operating cash flow and free cash flow. Constraints include structurally thin margins and volatility/outlier weakness noted in the 2025 figures (revenue and free-cash-flow decline), plus a modest upward drift in leverage versus earlier years.

Income Statement

Revenue has been broadly flat around ~CHF 11.0B across 2020–2024, with a sharp reported decline in 2025 (likely an outlier vs prior-year stability). Profitability is steady but thin: net margin sits near ~1.6%–2.0% and operating margin around ~2.3%–3.1%, which is typical of a high-volume, low-margin model but leaves limited buffer if costs rise. Net income is relatively stable (roughly CHF 157M–215M over the period), supporting a mid-range score despite modest growth and limited margin expansion.

Balance Sheet

Leverage looks manageable with debt-to-equity generally in the ~0.32–0.58 range, though it has moved higher versus 2020–2021 levels, reducing balance-sheet flexibility somewhat. Equity remains sizeable (~CHF 1.69B–1.82B), and returns to shareholders are consistently solid with return on equity around ~9%–12% across the period. Overall, the balance sheet appears stable, with the main watch item being the upward drift in leverage in recent years.

Cash Flow

Cash generation is steady: operating cash flow is consistently positive (~CHF 322M–393M), and free cash flow is also consistently positive (~CHF 237M–341M). Free cash flow tracks earnings well, running at roughly ~0.74–0.89x net income, which supports earnings quality. However, free cash flow growth has been volatile (notably negative in 2022 and 2024, and sharply negative in 2025), indicating uneven conversion and/or shifting working-capital and investment needs.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	11.07B	11.09B	11.07B	11.32B	11.11B
Gross Profit	746.90M	1.64B	759.70M	792.80M	770.50M
EBITDA	438.30M	472.00M	434.90M	437.30M	460.60M
Net Income	202.90M	214.80M	182.00M	201.10M	223.90M
Balance Sheet
Total Assets	5.50B	5.85B	5.47B	5.88B	5.35B
Cash, Cash Equivalents and Short-Term Investments	538.40M	609.10M	687.20M	636.40M	673.70M
Total Debt	942.30M	839.80M	958.20M	1.01B	587.10M
Total Liabilities	3.68B	3.97B	3.73B	4.05B	3.46B
Stockholders Equity	1.76B	1.82B	1.69B	1.76B	1.81B
Cash Flow
Free Cash Flow	284.70M	321.30M	340.80M	237.00M	338.20M
Operating Cash Flow	320.10M	362.90M	393.10M	321.90M	393.20M
Investing Cash Flow	-99.70M	-75.60M	-116.50M	-511.80M	-147.90M
Financing Cash Flow	-267.60M	-364.20M	-185.20M	180.70M	-239.50M

DKSH Holding AG Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 59.40
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:DKSH, the sentiment is Neutral. The current price of 59.4 is below the 20-day moving average (MA) of 61.11, below the 50-day MA of 59.48, and above the 200-day MA of 58.26, indicating a neutral trend. The MACD of -0.18 indicates Positive momentum. The RSI at 46.09 is Neutral, neither overbought nor oversold. The STOCH value of 51.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CH:DKSH.

DKSH Holding AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SFSN	73 Outperform	CHF4.60B	9.50	―	1.85%	-0.71%	-6.12%
DKSH	67 Neutral	CHF3.86B	18.40	―	4.14%	2.66%	2.91%
SGSN	67 Neutral	CHF17.42B	26.12	―	3.53%	3.12%	11.70%
VZN	64 Neutral	CHF5.78B	25.28	22.69%	1.82%	8.15%	12.24%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
KNIN	63 Neutral	CHF20.34B	23.05	―	4.81%	6.54%	-10.57%
ADEN	60 Neutral	CHF3.38B	14.14	―	4.46%	-4.68%	-5.79%

DKSH Holding AG Corporate Events

DKSH Delivers Higher Core Earnings and Margins as M&A and Healthcare Drive Growth

DKSH reported 2025 net sales of CHF 11.1 billion, up 2.9% at constant exchange rates, with Core EBIT rising 6.7% to CHF 349 million and margin improving to 3.2%, marking a fifth consecutive year of margin expansion. Strong free cash flow of CHF 215.5 million is supporting an accelerated M&A program and an increased dividend proposal, underscoring management’s confidence in its mid-term roadmap.

Healthcare remained the largest growth driver with above-GDP expansion and higher-margin business, while Consumer Goods and Performance Materials delivered modest constant-currency gains and margin improvements despite mixed demand and currency headwinds. The Technology unit held roughly steady amid delayed investments but was reshaped through five acquisitions and divestments, and board changes, including the proposed election of fifth-generation family representative Julie von Wedel-Keller, reinforce long-term family backing and governance continuity.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Extends Great Place to Work Certification to 16 Markets and Joins Fortune’s Best Employers in Southeast Asia

DKSH has expanded its Great Place to Work certification to 20 entities across 16 markets in Europe and Asia Pacific, including major locations such as Australia, China, Malaysia, Singapore, South Korea, Switzerland, and Thailand. The company has also been named among the “Fortune 100 Best Companies to Work For Southeast Asia 2025,” following extensive employee surveys that highlight strong collaboration, openness, supportive culture, and credible leadership. These recognitions underscore DKSH’s ongoing transformation toward a high-performing corporate culture that emphasizes quality management, talent development, diversity, and employee engagement, positioning the firm to better retain talent and deliver superior service to clients and customers across its key growth markets.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Names Natale Capri Sole Head of Performance Materials as Veteran Leader Retires

DKSH has reshaped the leadership of its Performance Materials business unit, appointing long-standing Co-Head Natale Capri as the sole Head of the unit and retaining him on the Executive Committee, while veteran executive Thomas Sul steps down from his Co-Head and Executive Committee roles as he transitions toward retirement. Sul leaves after nearly three decades with DKSH, during which he helped globalize Performance Materials, drive acquisitions, and double operating profit; he will continue to support the business in a strategic capacity into early 2026, providing continuity as Capri and his team are tasked with building on this track record and further strengthening the unit’s market position.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Secures SBTi Approval for Ambitious Net-Zero Emissions Targets

DKSH has secured official validation from the Science Based Targets initiative (SBTi) for its near-term and net-zero emissions targets, confirming that its climate strategy aligns with current climate science and the goals of the Paris Agreement. The company plans to reduce absolute Scope 1 and 2 emissions by 71.2% by 2030 versus a 2020 baseline, cut Scope 3 emissions from purchased goods and services by 61.1% per CHF of value added by 2033, and reach net-zero greenhouse gas emissions across its value chain by 2050, building on a 55% reduction in Scope 1 and 2 emissions already achieved since 2020 and strengthened carbon disclosure practices. DKSH is pursuing these goals through measures such as route and load optimization in transport, greater use of renewable electricity, fleet electrification, and investments in carbon removal projects, positioning sustainability as a core element of its business model and signaling long-term value creation for its operations, partners, and the communities it serves.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Expands in Vietnam with Biomedic Acquisition

DKSH has announced the acquisition of Biomedic Science Material Joint Stock Company, a prominent distributor in Vietnam’s biotechnology and diagnostic market. This strategic move aims to enhance DKSH Technology’s presence in the life science and healthcare sectors across Vietnam, leveraging Biomedic’s established customer base and expertise. The acquisition is expected to provide growth opportunities for DKSH and deliver benefits to business partners and employees.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH Expands in New Zealand and Australia with Invita Acquisition

DKSH has announced the acquisition of Invita (NZ) Limited and Invita Australia Pty Limited, enhancing its food and beverage business in New Zealand and Australia. This strategic move strengthens DKSH’s position in the Asia Pacific region’s life science and industrial specialties market, particularly in the dairy and nutritional segments. Invita, with over 35 years of experience, is known for its high-quality specialty ingredients and strong market presence. The acquisition is expected to provide a robust platform for future growth, leveraging both companies’ portfolios and customer relationships, and is anticipated to close by early 2026.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.

DKSH to Fully Acquire and Delist Malaysian Subsidiary

DKSH Holding Ltd., a prominent Market Expansion Services provider, has announced its intention to take full control of its Malaysian subsidiary, DKSH Holdings (Malaysia) Berhad, by acquiring the remaining 25.7% of shares from minority shareholders. This move is part of DKSH’s strategy to simplify its company structure and includes plans to delist the subsidiary from the Malaysian stock exchange. The proposed acquisition involves a Selective Capital Reduction mechanism, offering a 16.7% premium on the shares, and is expected to be finalized by the second or third quarter of 2026, pending necessary approvals.

The most recent analyst rating on (CH:DKSH) stock is a Buy with a CHF75.00 price target. To see the full list of analyst forecasts on DKSH Holding AG stock, see the CH:DKSH Stock Forecast page.